Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: J Neurooncol. 2013 May 11;114(1):79–84. doi: 10.1007/s11060-013-1150-2

Table 2.

Glioma survival in relation to recent pre-diagnostic body weight

BMI (Kg/m2)* Age-Adjusted Models** Multivariable Models
Number Deaths AHR (95% CI) Number Deaths AHR (95% CI)
Overall
 <18.5 13 9 2.02 (1.03, 3.96) 11 7 1.28 (0.60, 2.77)
 18.5– 24.9 251 164 referent 206 136 referent
 25–29.9 348 251 1.04 (0.85, 1.27) 300 221 1.16 (0.93, 1.45)
 ≥30 241 181 1.24 (1.00, 1.54) 195 143 1.32 (1.04, 1.68)
Males
 <18.5 5 4 2.48 (0.90, 6.84) 5 4 2.03 (0.73, 5.68)
 18.5–24.9 99 69 referent 83 59 referent
 25–29.9 243 182 1.10 (0.84, 1.46) 212 162 1.30 (0.96, 1.77)
 ≥30 159 122 1.30 (0.97, 1.75) 128 96 1.45 (1.04, 2.03)
Females
 <18.5 8 5 1.70 (0.69, 4.20) 6 3 1.06 (0.32, 3.50)
 18.5–24.9 152 95 referent 123 77 referent
 25–29.9 105 69 0.96 (0.70, 1.31) 88 59 1.01 (0.71, 1.42)
 ≥30 82 59 1.25 (0.91, 1.74) 67 47 1.29 (0.89, 1.87)
*

BMI (body mass index) 1 year (N=103) or 5 years (N=750) prior to glioma diagnosis

**

Hazard ratio (HR) and 95% confidence interval (CI) adjusted for age and in overall model, gender

Hazard ratio (HR) and 95% confidence interval (CI) adjusted for age, KPS, treatment, and in overall model, gender.

Abbreviations: BMI (body mass index); AHR (Adjusted Hazards Ratio); CI (Confidence Interval). Unequal cell counts comparing age-adjusted and multivariate models reflect missing data.